Latest filing published 26 May 2022 for Virpax Pharmaceuticals, Inc..
Insider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Jerrold Sendrow: trading record in brief
This profile gathers the share dealings of Jerrold Sendrow in Virpax Pharmaceuticals, Inc., where the filings describe the role as board member. Over a trading history stretching from 22 November 2021 to 24 May 2022, the count stands at 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €19k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2022 alone, the filings show 1 purchase and no sales.
Most recently, on 26 May 2022, the filings show an open-market purchase worth €5,407 in Virpax Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jerrold Sendrow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,500 shares@ €1.201528.5% of flowCommon Stock, $0.00001 par valueSEC:0001493152-22-015224:0Canonical exit: 22 Aug 2022 (T+90)
- 3,900 shares@ €3.480971.5% of flowCommon Stock, $0.00001 par valueSEC:0000905718-21-001536:0Canonical exit: 20 Feb 2022 (T+90)
2 of 2 declarations